UNICA IRIS Institutional Research Information System

PISTIS, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 195.360
NA - Nord America 7.715
AS - Asia 2.994
SA - Sud America 539
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 206.686
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 193.338
US - Stati Uniti d'America 7.612
CN - Cina 1.275
SG - Singapore 1.171
SE - Svezia 583
UA - Ucraina 550
BR - Brasile 447
DE - Germania 245
GB - Regno Unito 207
VN - Vietnam 190
FI - Finlandia 149
FR - Francia 92
KR - Corea 81
CA - Canada 67
HK - Hong Kong 47
IN - India 45
AR - Argentina 42
NL - Olanda 37
PL - Polonia 31
AT - Austria 30
TR - Turchia 27
BD - Bangladesh 23
IQ - Iraq 22
MX - Messico 21
ZA - Sudafrica 19
ES - Italia 18
JP - Giappone 18
RU - Federazione Russa 18
MA - Marocco 15
BE - Belgio 13
IL - Israele 13
CZ - Repubblica Ceca 11
EC - Ecuador 11
EG - Egitto 11
EU - Europa 9
ID - Indonesia 9
UZ - Uzbekistan 9
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
PK - Pakistan 7
AU - Australia 6
AZ - Azerbaigian 6
IE - Irlanda 6
IR - Iran 6
LT - Lituania 6
PY - Paraguay 6
CH - Svizzera 5
CR - Costa Rica 5
PE - Perù 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
NP - Nepal 4
PH - Filippine 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
JM - Giamaica 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KI - Kiribati 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
Totale 206.684
Salva come PNG Salva come JPEG
Città #
Cagliari 188.984
Uta 3.894
Fairfield 915
Ashburn 673
Woodbridge 641
Singapore 534
Chandler 435
Houston 416
Boardman 394
Dallas 385
Ann Arbor 383
Nyköping 339
Seattle 338
Wilmington 338
Cambridge 301
Jacksonville 267
Beijing 247
Dearborn 194
Los Angeles 142
Santa Clara 129
Shanghai 125
Hefei 115
New York 112
Nanjing 105
Boston 94
Seoul 79
Helsinki 67
Buffalo 63
Ho Chi Minh City 62
San Diego 52
Dong Ket 46
Hong Kong 46
Guangzhou 45
São Paulo 43
Milan 38
Munich 38
Nanchang 38
London 36
Hebei 32
Rome 31
Shenyang 31
Redwood City 29
Hanoi 28
Redondo Beach 28
Warsaw 27
The Dalles 26
Tianjin 26
Chicago 25
Mountain View 24
Frankfurt am Main 23
Jiaxing 22
Vienna 21
Nuremberg 20
Toronto 19
Jinan 18
Norwalk 18
Denver 17
Brooklyn 16
Kunming 16
San Francisco 16
Atlanta 15
Montreal 14
Brussels 13
Changsha 13
Phoenix 13
Tokyo 13
Verona 13
Washington 13
Auburn Hills 12
Augusta 12
Orange 12
Orem 12
Porto Alegre 12
San Mateo 12
Sèlegas 12
Amsterdam 10
Casablanca 10
Johannesburg 10
Rio de Janeiro 10
Sassari 10
Stockholm 10
Taizhou 10
Wuhan 10
Zhengzhou 10
Brasília 9
Leawood 9
Ningbo 9
Tashkent 9
Ankara 8
Baghdad 8
Cairo 8
Council Bluffs 8
Monmouth Junction 8
Poplar 8
Quartu Sant'elena 8
Victoria 8
Brno 7
Chennai 7
Düsseldorf 7
Lauterbourg 7
Totale 202.075
Salva come PNG Salva come JPEG
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.717
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.574
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.126
Maternal immune activation disrupts dopamine system in the offspring 4.084
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.435
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.339
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.329
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.048
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 2.977
null 2.940
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.760
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.711
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.678
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.558
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.504
null 2.498
Effects of maternal immune activation on dopamine activity in male and female offspring 2.415
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.412
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.331
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.322
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.286
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.195
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.155
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.124
Trattamenti farmacologici per la dipendenza da nicotina 2.010
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 1.996
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 1.984
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 1.945
The role of nuclear hormone receptors in cannabinoid function 1.918
Pharmacological treatments for nicotine dependence 1.881
Opposite responses to aversive stimuli in lateral habenula neurons 1.870
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.825
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.812
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.806
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.777
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.774
Neurobiologia della dipendenza da nicotina 1.764
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.759
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.746
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.735
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.728
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.686
Neurobiology of nicotine addiction 1.635
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.626
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.584
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.579
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.569
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.541
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.539
The endocannabinoid system and nondrug rewarding behaviours 1.439
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.425
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.395
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.391
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.350
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.333
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.328
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.323
Neurobiological mechanisms of cannabinoid addiction 1.264
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.231
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.137
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.111
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.096
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.071
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1.069
Endocannabinoids and the processing of value-related signals 1.057
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.038
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.022
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 988
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 944
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 900
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 896
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 852
null 850
null 841
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 821
null 800
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 793
From surface to nuclear receptors: the endocannabinoid family extends its assets 772
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 771
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 761
null 747
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 744
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 713
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 709
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 700
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 692
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 682
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. 676
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 673
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug-resistant epilepsy (DRE) 670
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 660
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 629
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 612
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 588
Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation 543
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 532
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice 516
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 505
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity 492
Totale 195.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 258.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 258.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115.860 0 0 0 0 0 4.482 3.079 2.280 1.003 1.933 2.021 1.062
2021/202211.101 1.050 879 586 682 1.013 908 564 469 602 1.328 1.738 1.282
2022/202314.067 990 1.397 1.327 1.089 1.323 1.647 733 1.299 1.120 1.051 1.430 661
2023/202449.892 661 572 541 856 1.483 2.459 2.645 1.114 938 903 1.646 36.074
2024/202521.159 3.853 4.782 2.869 3.011 1.650 1.684 1.801 186 397 251 382 293
2025/20264.242 871 452 999 787 665 468 0 0 0 0 0 0
Totale 207.061